Our Scientists
Our versatile team of scientists, working with advanced technology platforms, were instrumental in the assay development and testing that supported the FDA filing of almost 350 new molecular entities, including blockbuster vaccines, antiviral drugs, plus immunotherapy, cell, and gene therapy products.
Let’s take a moment to meet the people that guide the science behind What’s Next in Immunology.

Anne Katrin Hilbert
Vaccine
Aimee Rinas
Bioanalytical
Chloe Ackaert
Early Development
Jana Schockaert
Early Development
Steven-Phay Tran
Vaccine
Francesco Lipari
Immunochemistry
Julien St-Jean
Vaccine
Danielle Poirier
Preclinical
Sofie Pattijn
Early Development
David Skibinski
Biomarker, Bioanalytical
Luc Gagnon
Vaccine